Please use this identifier to cite or link to this item: https://doi.org/10.1039/c9na00248k
DC FieldValue
dc.titleA MoS2-MWCNT based fluorometric nanosensor for exosome detection and quantification
dc.contributor.authorTayebi, M.
dc.contributor.authorTavakkoli Yaraki, M.
dc.contributor.authorYang, H.Y.
dc.contributor.authorAi, Y.
dc.date.accessioned2021-12-17T06:08:27Z
dc.date.available2021-12-17T06:08:27Z
dc.date.issued2019
dc.identifier.citationTayebi, M., Tavakkoli Yaraki, M., Yang, H.Y., Ai, Y. (2019). A MoS2-MWCNT based fluorometric nanosensor for exosome detection and quantification. Nanoscale Advances 1 (8) : 2866-2872. ScholarBank@NUS Repository. https://doi.org/10.1039/c9na00248k
dc.identifier.issn25160230
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/210979
dc.description.abstractCirculating exosomes in body fluids are involved in many diseases and have important roles in pathophysiological processes. Specifically, they have emerged as a promising new class of biomarkers in cancer diagnosis and prognosis because of their high concentration and availability in a variety of biological fluids. The ability to quantitatively detect and characterize these nano-sized vesicles is crucial to make use of exosomes as a reliable biomarker for clinical applications. However, current methods are mostly technically challenging and time-consuming which prevents them from being adopted in clinical practice. In this work, we have developed a rapid sensitive platform for exosome detection and quantification by employing MoS2-multiwall carbon nanotubes as a fluorescence quenching material. This exosome biosensor shows a sensitive and selective biomarker detection. Using this MoS2-MWCNT based fluorometric nanosensor to analyze exosomes derived from MCF-7 breast cancer cells, we found that CD63 expression could be measured based on the retrieved fluorescence of the fluorophore with a good linear response range of 0-15% v/v. In addition, this nanosensing technique is able to quantify exosomes with different surface biomarker expressions and has revealed that exosomes secreted from MCF-7 breast cancer cells have a higher CD24 expression compared to CD63 and CD81. © 2019 The Royal Society of Chemistry.
dc.publisherRoyal Society of Chemistry
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScopus OA2019
dc.typeArticle
dc.contributor.departmentDEPT OF CHEMICAL & BIOMOLECULAR ENGG
dc.description.doi10.1039/c9na00248k
dc.description.sourcetitleNanoscale Advances
dc.description.volume1
dc.description.issue8
dc.description.page2866-2872
Appears in Collections:Students Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1039_c9na00248k.pdf1.48 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

15
checked on Dec 17, 2021

Page view(s)

14
checked on Dec 1, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons